A complete application in a minute
Tailored resume and cover letter, ready to send.
Orion Group is seeking a Scientist II, Biologics CMC Developability for an onsite role in North Chicago, IL. You will evaluate biologics candidates, analyzing stability and manufacturability challenges early in development, collaborating with Discovery, Analytical, and Process R&D teams to inform decisions.
The ideal candidate has a background in biochemistry or related discipline and hands-on experience with protein characterization techniques such as DSF/DSC, HPLC, and other biotech analytical
Hourly Rate: $48 - $52/hr with medical benefits available at a cost.
Contract Length: 1 year initial contract with possibility of extension.
Location: Onsite in North Chicago, IL
Orion Project Services has teamed up with a market leading pharmaceutical company on an exciting contract opportunity for a Scientist II, Biologics CMC Developability in North Chicago, Illinois.
In this onsite role, you’ll help assess promising biologic drug candidates and identify potential stability, formulation, and manufacturing challenges early in development. You’ll work with scientists across Discovery, Analytical, and Process R&D, using techniques such as DSF/DSC, viscosity testing, and biologics characterization to inform development decisions. The work spans a variety of therapeutic biologics, including monoclonal antibodies, bispecifics, ADCs, and fusion proteins.
The Biologics CMC Developability (BCD) group sits at the interface of discovery and development. The core role of BCD is to generate developability insights that inform candidate selection, molecular optimization, and advancement decisions across the biologics pipeline. Developability assessments focus on identifying manufacturability, formulation, stability, and product quality risks early in development to enable selection of robust drug candidates. Our team works across a wide range of therapeutic areas and diverse classes of biologics therapeutics, including monoclonal antibodies, bispecific and multispecific antibodies, antibody drug conjugates (ADC), fusion proteins, and emerging biologic modalities.
We are looking for a highly motivated person to support these developability efforts and early-stage assessment of candidates to move our ever-evolving pipeline forward. In this role, the candidate will be part of a global team and will work closely with scientists from multiple functional areas, including Discovery, Analytical, and Process R&D.